Back to Search
ROSEMARY GEARY, M.D.
M.D.
Dermatology Physician
NPI: 1467431668IndividualAccepts Medicare
Specialties, Licenses & Credentials
Dermatology PhysicianPrimary
Dermatology
Code: 207N00000X
26816(AZ)
CMS Specialties
PrimaryDERMATOLOGY
Education
UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE
Class of 1994
Research & Publications (20)
Lack of pharmacokinetic interaction of mipomersen sodium (ISIS 301012), a 2'-O-methoxyethyl modified antisense oligonucleotide targeting apolipoprotein B-100 messenger RNA, with simvastatin and ezetimibe.
PMID 19071883·Clin Pharmacokinet·2009
3-trial
Cross-species comparison of in vivo PK/PD relationships for second-generation antisense oligonucleotides targeting apolipoprotein B-100.
PMID 19056355·Biochem Pharmacol·2009
4-observational
Efficient recovery of endothelial progenitors for clinical translation.
PMID 19125587·Tissue Eng Part C Methods·2009
7-preclinical
Effect of dose and plasma concentration on liver uptake and pharmacologic activity of a 2'-methoxyethyl modified chimeric antisense oligonucleotide targeting PTEN.
PMID 19393225·Biochem Pharmacol·2009
7-preclinical
The in vivo stability of electrospun polycaprolactone-collagen scaffolds in vascular reconstruction.
PMID 18990437·Biomaterials·2009
7-preclinical
Antisense oligonucleotide pharmacokinetics and metabolism.
PMID 19379126·Expert Opin Drug Metab Toxicol·2009
6-review
Restenosis after renal artery angioplasty and stenting: incidence and risk factors.
PMID 19595532·J Vasc Surg·2009
8-other
RGS5, RGS4, and RGS2 expression and aortic contractibility are dynamically co-regulated during aortic banding-induced hypertrophy.
PMID 18207159·J Mol Cell Cardiol·2008
7-preclinical
Synaptic function for the Nogo-66 receptor NgR1: regulation of dendritic spine morphology and activity-dependent synaptic strength.
PMID 18337405·J Neurosci·2008
4-observational
Inhaled CD86 antisense oligonucleotide suppresses pulmonary inflammation and airway hyper-responsiveness in allergic mice.
PMID 17389243·J Pharmacol Exp Ther·2007
7-preclinical
Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL.
PMID 17332893·J Clin Invest·2007
8-other
Cross-species pharmacokinetic comparison from mouse to man of a second-generation antisense oligonucleotide, ISIS 301012, targeting human apolipoprotein B-100.
PMID 17172312·Drug Metab Dispos·2007
3-trial
Anti-inflammatory activity of inhaled IL-4 receptor-alpha antisense oligonucleotide in mice.
PMID 16990616·Am J Respir Cell Mol Biol·2007
7-preclinical
Bioavailability and therapeutic activity of alicaforsen (ISIS 2302) administered as a rectal retention enema to subjects with active ulcerative colitis.
PMID 16669957·Aliment Pharmacol Ther·2006
3-trial
Plasma protein binding of an antisense oligonucleotide targeting human ICAM-1 (ISIS 2302).
PMID 16764540·Oligonucleotides·2006
7-preclinical
Distal embolic protection during renal artery angioplasty and stenting.
PMID 16828436·J Vasc Surg·2006
8-other
Lack of pharmacokinetic interaction for ISIS 113715, a 2'-0-methoxyethyl modified antisense oligonucleotide targeting protein tyrosine phosphatase 1B messenger RNA, with oral antidiabetic compounds metformin, glipizide or rosiglitazone.
PMID 16884318·Clin Pharmacokinet·2006
3-trial
Acute pancreatitis: A complication associated with rheolytic mechanical thrombectomy of deep venous thrombosis.
PMID 17098552·J Vasc Surg·2006
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1100 S DOBSON RD STE 223
CHANDLER, AZ 85286 - Phone
- (480) 821-8888
Quick Facts
- NPI
- 1467431668
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 32
- Publications
- 20
Are you this provider?
Claim Your Profile